All In Biotech

Drug Trial Radar · NCT06073665

Dosing of LT4 in Older Individuals

Levothyroxine Dosing in Older Individuals

Last checked: Nov 20, 2026Latest source record: Feb 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 228 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

228

Planned (sponsor's estimate)

Start

Jan 31, 2024

Primary completion

Apr 1, 2028

Study completion Apr 1, 2028

Sponsor

Lead sponsor
University of PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Aging (NIA)
First posted
Oct 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.

Conditions

  • Hypothyroidism

Interventions

  • Levothyroxine SodiumDrug

    Levothyroxine dose will depend on dose at baseline and randomization group

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Thyroid-Related Quality of Life Patient-Reported Outcome Quality of Life scaleTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Penn Medicine, Smilow Translational Research Center

    Philadelphia, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.